(2832) Gepotidacin Efficacy in E. coli Drug-Resistant Phenotypes: A Pooled Analysis of the EAGLE-2 and EAGLE-3 Randomized Controlled Trials in Uncomplicated Urinary Tract Infection

Saturday, October 14, 2023

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Presenting Author(s)

Thomas M. Hooton, MD (he/him/his)

Voluntary Professor of Clinical Medicine
University of Miami
Coral Gables, FL, United States

Caroline R. Perry, PhD (she/her/hers)

Sr Clinical Development Director
GSK, Collegeville, PA, USA
Collegeville, Pennsylvania, United States
SJ

Salim Janmohamed, MD

GSK, Brentford, UK
Brentford, England, United Kingdom
AS

Amanda Sheets, PhD

GSK, Collegeville, PA, USA
Collegeville, Pennsylvania, United States
JD

Jeremy Dennison, MD

GSK, Brentford, UK
Brentford, England, United Kingdom
HM

Helen Millns, PhD

GSK, Stevenage, UK
Stevenage, England, United Kingdom
EJ

Emily Jarvis, MSc

GSK, Stevenage, UK
Stevenage, England, United Kingdom
NS

Nicole E. Scangarella-Oman, MS

Scientific Director
GlaxoSmithKline plc.
Collegeville, Pennsylvania, United States
CH

Chun Huang, PhD

GSK, Collegeville, PA, USA
Collegeville, Pennsylvania, United States